Susquehanna International Group’s Leap Therapeutics LPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.5K | Sell |
48,770
-241,273
| -83% | -$71.6K | ﹤0.01% | 6178 |
|
2025
Q1 | $88.5K | Buy |
290,043
+63,955
| +28% | +$19.5K | ﹤0.01% | 5891 |
|
2024
Q4 | $650K | Buy |
226,088
+159,842
| +241% | +$460K | ﹤0.01% | 3666 |
|
2024
Q3 | $170K | Buy |
66,246
+54,271
| +453% | +$139K | ﹤0.01% | 4897 |
|
2024
Q2 | $23.5K | Sell |
11,975
-17,492
| -59% | -$34.3K | ﹤0.01% | 5375 |
|
2024
Q1 | $78.4K | Sell |
29,467
-98,074
| -77% | -$261K | ﹤0.01% | 5074 |
|
2023
Q4 | $529K | Buy |
+127,541
| New | +$529K | ﹤0.01% | 3783 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 6010 |
|
2023
Q2 | – | Sell |
-1,497
| Closed | -$5.09K | – | 6141 |
|
2023
Q1 | $5.09K | Sell |
1,497
-1,535
| -51% | -$5.22K | ﹤0.01% | 5791 |
|
2022
Q4 | $13.6K | Sell |
3,032
-1,152
| -28% | -$5.18K | ﹤0.01% | 5427 |
|
2022
Q3 | $37K | Sell |
4,184
-3,171
| -43% | -$28K | ﹤0.01% | 5584 |
|
2022
Q2 | $85K | Sell |
7,355
-5,255
| -42% | -$60.7K | ﹤0.01% | 5073 |
|
2022
Q1 | $221K | Sell |
12,610
-2,656
| -17% | -$46.5K | ﹤0.01% | 4698 |
|
2021
Q4 | $495K | Buy |
+15,266
| New | +$495K | ﹤0.01% | 3832 |
|
2020
Q2 | – | Sell |
-2,875
| Closed | -$45K | – | 4618 |
|
2020
Q1 | $45K | Buy |
2,875
+1,225
| +74% | +$19.2K | ﹤0.01% | 4234 |
|
2019
Q4 | $18K | Buy |
+1,650
| New | +$18K | ﹤0.01% | 3861 |
|
2018
Q1 | – | Sell |
-5,223
| Closed | -$326K | – | 4020 |
|
2017
Q4 | $326K | Buy |
+5,223
| New | +$326K | ﹤0.01% | 2767 |
|